Position in DXCM
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$16,767
-$688 QoQ
Shares Held
267
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026American Capital Advisory, LLC holds $126,363 across 17 Medical Devices names. DXCM ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
661 | $67,864 | |
| 2 | EW |
Edwards Lifesciences Corp
|
262 | $20,980 | |
| 3 | DXCM |
Dexcom Inc
This page
|
267 | $16,767 | |
| 4 | MDT |
Medtronic plc
|
52 | $4,505 | |
| 5 | BSX |
Boston Scientific Corp
|
55 | $3,451 | |
| 6 | SYK |
Stryker Corp
|
9 | $2,957 | |
| 7 | PHG |
Koninklijke Philips NV
|
70 | $1,918 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
24 | $1,708 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,767 | 267 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $17,455 | 263 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $17,428 | 259 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $22,695 | 260 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $17,072 | 250 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $19,442 | 250 | Shares | Sole | 2025-01-28 | |
| 2024-06-30 | $21,542 | 190 | Shares | Sole | 2024-07-29 | |
| 2023-12-31 | $23,577 | 190 | Shares | Sole | 2024-04-09 | |
| No filing history on record for this holder in this stock. | ||||||